The ALLHAT and the Cardioprotection Conferred by Diuretics in Hypertensive Patients: A Connection with Uric Acid? Ariel J. ReyesWilliam P. Leary Editorial Introduction Pages: 485 - 487
Specific Drug Delivery to the Kidney Marijke HaasFrits MoolenaarDick de Zeeuw OriginalPaper Pages: 489 - 496
Cardiovascular Therapy in Patients with Renal Insufficiency Luis M. RuilopeJulian Segura OriginalPaper Pages: 497 - 501
Treatment of Hypertension in Patients with Renal Disease Jay GargGeorge L. Bakris OriginalPaper Pages: 503 - 510
Antioxidant Effects and Anti-Elastase Activity of the Calcium Antagonist Nicardipine on Activated Human and Rabbit Neutrophils—A Potential Antiatherosclerotic Property of Calcium Antagonists? Ferdinand KouohBernard GressierJean Claude Cazin OriginalPaper Pages: 515 - 520
In Vitro Ultrasound Augmented Clot Dissolution—What is the Optimal Timing of Ultrasound Application? Gil Zvi ShlamovitzZaza IakobishviliYochai Birnbaum OriginalPaper Pages: 521 - 526
Efficacy of Percutaneous Intramyocardial Injections Using a Nonfluoroscopic 3-D Mapping Based Catheter System Pieter C. SmitsGlenn van LangenhovePatrick W. Serruys OriginalPaper Pages: 527 - 533
Efficacy of Transdermal Nitroglycerin Patches Evaluated by Dipyridamole-Induced Myocardial Ischemia in Patients with Coronary Artery Disease. Comparison Between Continuous and Intermittent Schedule Giancarlo LongobardiNicola FerraraFranco Rengo OriginalPaper Pages: 535 - 542
Clinical Profile of Eprosartan Juan García PuigMaría A. Martínez LópezRosa Torres Jiménez OriginalPaper Pages: 543 - 549
Pretreatments with a Novel Pure Potassium Channel Blocker, Nifekalant, were Effective in the Electrical Atrial Defibrillation: A Report of Two Cases Gaku SekitaDaigo SawakiTeruhiko Aoyagi Legacy Pages: 551 - 552
